Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, signed a strategic partnership with PharmaLinkFHI (PharmaLink), the industry's leading electronic clinical research organization (eCRO).

Through Medidata's ASPire to Win programme, PharmaLink will expand its capabilities in electronic data capture, management and analysis with Medidata Rave. The companies' collaboration will provide biopharmaceutical companies earlier visibility into the critical clinical data that leads to better-informed decision making, resource allocation and risk management.

Medidata's ASPire to Win program is a non-exclusive application service provider (ASP) partnership and business model, enabling CROs to easily become Medidata Ravecertified to implement comprehensive electronic clinical trials management - offering CROs the opportunity to quickly generate new revenue streams around the technology.

"PharmaLink's goal is to deliver more effective trial management by combining clinical expertise with leading technologies. By leveraging a solution like Medidata Rave for real-time access and reporting, we're able to provide our customers with greater collaboration, more effective management of sites and study teams and improved decision making," said W. Richard Staub, president and COO of PharmaLink.

PharmaLink is a new breed of clinical research organization managing Phase I-IV clinical trials and post-marketing programs online in real time. From protocol development through final clinical study report, PharmaLink integrates deep clinical know-how with industry leading technologies, engaging the entire clinical team with actionable intelligence for more confident decision-making and risk management.